{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:47:39Z","timestamp":1747763259651,"version":"3.40.5"},"reference-count":80,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2021,5,4]]},"DOI":"10.1080\/17474086.2021.1938533","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T20:51:28Z","timestamp":1622667088000},"page":"407-417","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia"],"prefix":"10.1080","volume":"14","author":[{"given":"Tamer A.","family":"Othman","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Tenold","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin N.","family":"Moskoff","sequence":"additional","affiliation":[{"name":"Pharmacy Department, University of California Davis School of Medicine, Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tali","family":"Azenkot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-5809","authenticated-orcid":false,"given":"Brian A.","family":"Jonas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.04.005"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2018-000807"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235358"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0612-8"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01600"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj112"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.12.013"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.395"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0609"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3788"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.44"},{"key":"cit0014","unstructured":"AbbVie Inc. VENCLEXTA (venetoclax) [package insert]. U.S. Food and Drug Administration website. [cited 2021 Jan 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/208573s009lbl.pdf."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-868752"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-172007"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3724"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.303"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0281-x"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.08.006"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.99.99"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0060"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23924"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-480228"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902688"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779405"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716984"},{"key":"cit0028","doi-asserted-by":"crossref","unstructured":"Sallman DA, Asch AS, Kambhampati S, et al. Abstract 330. The first-in-class anti-CD47 antibody magrolimab combined with azacitidine is well-tolerated and effective in AML patients: phase 1b results. Am Soc Hematol. 2020;136:5\u20138.","DOI":"10.1182\/blood-2019-126271"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-131055"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.7506"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-828269"},{"issue":"2","key":"cit0032","first-page":"98","volume":"80","author":"Bensi L","year":"1995","journal-title":"Haematologica"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1537-8"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.10.005"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0233-1"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1038\/nature03579"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.97"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.741"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.071613"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.01.003"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0313"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30010-X"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26039"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004856"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134789"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134820"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139923"},{"key":"cit0049","unstructured":"[cited 2021 Jan 4]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/azacitidine-celgene. Accessed 2021 Jan 4."},{"key":"cit0050","unstructured":"[cited 2021 Jan 4]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/orphan-designations\/eu306370."},{"key":"cit0051","unstructured":"[cited 2021 Jan 4]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/orphan-designations\/eu3161617."},{"key":"cit0052","unstructured":"Administration AGDOHTG. [cited 2021 Jan 4]. Available from: AustralianPublicAssessmentReportforVenetoclaxhttps:wwwtgagovausitesdefaultfilesausparvenetoclax200924docx."},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140646"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30210-6"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134300"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00376-1"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134718"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136968"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139884"},{"key":"cit0060","doi-asserted-by":"crossref","unstructured":"Tm BG K, Pemmaraju N, Daver N, et al. Abstract 25. phase ii study of venetoclax added to cladribine + low dose araC (LDAC) alternating with 5-azacytidine demonstrates high rates of minimal residual disease (MRD) negative complete remissions (CR) and excellent tolerability in older patients with newly diagnosed acute myeloid leukemia (AML)Blood 2020; 136 (Supplement 1):17\u201319.","DOI":"10.1182\/blood-2020-142092"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.7500"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.252569"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404434"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1808213"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-010-0048-8"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29428"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.003"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0710"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3383-5"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.07.021"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003988"},{"key":"cit0072","first-page":"125","volume":"4","author":"Saliba AN","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.08.027"},{"issue":"3","key":"cit0074","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ajh.25369","volume":"94","author":"Mei M","year":"2019","journal-title":"Am J Hematol"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001239"},{"key":"cit0076","unstructured":"https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf Accessed 2021 Jan 4."},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134832"},{"key":"cit0078","unstructured":"VIDAZA (azacitidine) [package insert]. U.S. food and drug administration website. [cited 2021 Jan 4]. Available from: https:\/\/www.accessdatafdagov\/drugsatfda_docs\/label\/2008\/050794s011lblpdf."},{"key":"cit0079","unstructured":"DACOGEN (decitabine) [package insert] U.S. food and drug administration website. [cited 2021 Jan 4]. Available from: https:\/\/www.accessdatafdagov\/drugsatfda_docs\/label\/2010\/021790s006lblpdf]."},{"key":"cit0080","unstructured":"[cited 2021 Jan 4]. Available from: https:\/\/www.leukemia-net.org\/content\/home\/index_eng.html."}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2021.1938533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T12:35:44Z","timestamp":1699101344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2021.1938533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,4]]}},"alternative-id":["10.1080\/17474086.2021.1938533"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2021.1938533","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"type":"print","value":"1747-4086"},{"type":"electronic","value":"1747-4094"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}